Page 2447 - Williams Hematology ( PDFDrive )
P. 2447

2418           Index                                                                                                                                                                                               Index         2419




               Colony-forming unit-granulocyte-monocyte   Complement system             Congenital thrombotic thrombocytopenic
                       (CFU-GM), 100, 263             deficiencies, 1213t, 1232                purpura (Upshaw-Schulman
                 in aplastic anemia, 515              in inflammation, 286t, 289–290, 289f     syndrome), 2257–2258
               Colony-stimulating factor (CSF), 105,   Complete cytogenic response (CCyR), 1452t  Congestive heart failure, history of, 5
                       939–940                      Complete hematologic response (CHR),   Congo red stain, 1773, 1776, 1776f
               Colony-stimulating factor (CSF)-1, 1287     1452t                        Conjugated estrogens, for uremia, 2084
               Colton blood group/antigens, 2331t, 2345t  Complete molecular response (CMR), 1452t  Connective tissue tumors, polycythemia
               Combined immunodeficiencies (CID)    Computed tomography (CT), in pulmonary     with, 879
                 Ca  entry channel defects, 1221           embolism, 2271, 2272f        Consciousness, history of impairment of, 5
                   2+
                 CD27 deficiency, 1220              Concentrate film, 29                Consensus E-box motifs (CANNTG), 262
                 clinical features, 1213t           Conditional ablation, suicide genes for, 416  Constant region, 1175
                 coronin-1A deficiency, 1220        Confusion, history of, 5            Constipation, history of, 5
                 CTPS1 deficiency, 1220–1221        Congenital adrenal hyperplasia, 560  Co  phenotype, 2343
                                                                                          null
                 dedicator of cytokinesis 9 deficiency,   Congenital alopecia and absence of thymus,   Cooley anemia, 743. See also β-thalassemias
                       1221–1222                           1223                         Coombs (direct antiglobulin) test, 823, 833,
                 defects of T-cell–receptor signaling, 1220  Congenital amegakaryocytic        834t, 2349, 2372
                 magnesium transporter 1 defects, 1221     thrombocytopenia (CAMT), 530t,   COPP-ABVD regimen, for Hodgkin
                 major histocompatibility complex class I   532, 1822                          lymphoma, 1612t, 1614
                       deficiency, 1221             Congenital disorder of glycosylation II. See   Copper, 652t, 811
                 major histocompatibility complex class II   Leukocyte adhesion deficiency type   Copper deficiency, 653
                       deficiency, 1221                    2 (LAD-2)                      neutropenia and, 995
                 with multiple intestinal atresia, 1222  Congenital dyserythropoietic anemias, 608  sideroblastic anemia and, 919–920
                 Omenn syndrome, 1166, 1219–1220    Congenital dyserythropoietic anemias   COPP regimen
                 severe. See Severe combined               (CDAs), 563–569                for diffuse large B-cell lymphoma,
                       immunodeficiency (SCID)        atypical, 568, 568t                      1628–1629
                 T-cell immunodeficiencies with impaired   definition and history, 563    for Hodgkin lymphoma, 1612t
                       NF-κB activation, 1220         differential diagnosis, 563, 564f, 568–569,   Coproporphyrinogen oxidase (CPO), 895
                 with venoocclusive disease, 1222          637                          Coproporphyrinogens, 891f, 891t, 893f
               Combined system disease, 602, 602f     epidemiology, 563–564             Copy-number neutral LOH, 174, 177f
               COMMD7, 1853                           type I                            Copy number variants (CNVs), 147
               Common lymphoid progenitor (CLP),       clinical features, 564–565, 566f  Cord blood, 102, 357, 358
                       269–270, 1151                   genetics, 565–566                Cord colitis, 357
               Common myeloid progenitor (CMP),        laboratory features, 565, 565f   Cordocentesis, 854
                       270–271, 1151                   therapy, course, and prognosis, 566  Coronary artery bypass grafting, 2296
               Common variable immunodeficiency       type II                           Coronary artery disease, 1850, 2240. See also
                       (CVID), 993, 1214t, 1216, 1575t  clinical and laboratory features,      Cardiovascular disease
               Compartment syndrome, 2118                  566–567                      Coronary stents, 2293
               Compatibility testing, 2349–2350, 2350t  genetics, 567                   Coronin-1A deficiency, 1220
               Competitive repopulation, 259           therapy, course, and prognosis, 567–568  Cor pulmonale, 882
               Complement                             type III, 568                     Corrected count increment (CCI), 2385,
                 in antiphospholipid syndrome, 2237  Congenital erythropoietic porphyria (CEP),   2387–2388
                 defects, in atypical hemolytic uremic     889, 896–897                 Corrinoids, 588
                       syndrome, 2259–2260, 2259t     clinical features, 890t, 896f, 897  Corrin ring, 588, 588f, 589f
                 in paroxysmal nocturnal hemoglobinuria,   definition and history, 890, 896  Corynebacterium diphtheriae pharyngitis, 1268
                       572, 573f                      diagnosis, 897                    Cost antigens, 2333t
               Complementarity determining region     enzymes affected by, 890t         Cough, history of, 5
                       (CDRs), 1170                   laboratory features, 891t         Coumadin. See Warfarin
               Complementary DNA (cDNA)               pathogenesis of clinical findings, 897  Coumarin, 393
                 in Fanconi anemia, 530               pathophysiology, 896              Cow’s milk anemia, 630
                 libraries, 421                       therapy, 897                      COX. See under Cyclooxygenase (COX)
                 von Willebrand factor, 2164        Congenital Heinz body hemolytic anemia,   CPB2, 1935–1936
               Complement (C3)-coated red cells, 499       781–782                      Cpg islands, 168
               Complement fixation, 829             Congenital immunodeficiency diseases. See   CPO, 905
               Complement receptor 1, 815, 1054            Immunodeficiency diseases    CPO (coproporphyrinogen oxidase), 895
               Complement receptor 3. See CD11b     Congenital leukemia, 1386           CPX-351, for myelodysplastic syndromes,
               Complement receptors, 1053f, 1054    Congenital neutropenia, 992–993, 993f      1361








          Kaushansky_index_p2393-2506.indd   2418                                                                       9/21/15   3:21 PM
   2442   2443   2444   2445   2446   2447   2448   2449   2450   2451   2452